Treatment of the depressive phase of bipolar affective disorder: a review
- PMID: 23901682
Treatment of the depressive phase of bipolar affective disorder: a review
Abstract
Bipolar disorder is a chronic mood disorder which usually has its onset in adolescence and young adulthood. The disorder is typified by a remitting and relapsing course. While remissions are often partial in nature, relapses are frequent and manifested as manic, mixed, hypomanic and depressive episodes. Rapid cycling is a particularly disabling form of bipolar disorder, characterised by four or more episodes in a 12-month period. Bipolar disorder inevitably causes impairment in social and occupational functioning. Many patients experience severe hopelessness and suicidal ideation and the disorder is associated with one of the highest mortality rates of all psychiatric disorders. The treatment of bipolar depression is particularly challenging and numerous patients achieve incomplete benefit even with complex psychopharmacological strategies. In recent years, many new pharmacological options have become available for the treatment of bipolar depression and the field has seen significant progress. In order to achieve better outcome for the patients, it is mandatory that treating physicians have an up to date knowledge of recent advances in the management of this condition.
Similar articles
-
Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.J Affect Disord. 2005 Apr;85(3):245-58. doi: 10.1016/j.jad.2004.12.004. J Affect Disord. 2005. PMID: 15780694
-
Treatment of rapid cycling bipolar disorders.Neuro Endocrinol Lett. 2005 Aug;26 Suppl 1:67-73. Neuro Endocrinol Lett. 2005. PMID: 16361989 Review.
-
Effectiveness and mood conversion rate of short-term fluoxetine monotherapy in patients with rapid cycling bipolar II depression versus patients with nonrapid cycling bipolar II depression.J Clin Psychopharmacol. 2013 Jun;33(3):420-4. doi: 10.1097/JCP.0b013e31828ea89e. J Clin Psychopharmacol. 2013. PMID: 23609385 Clinical Trial.
-
Anticonvulsants in bipolar disorder.Psychiatr Clin North Am. 2005 Jun;28(2):301-23. doi: 10.1016/j.psc.2005.02.004. Psychiatr Clin North Am. 2005. PMID: 15826734 Review.
-
Prevalence and humanistic impact of potential misdiagnosis of bipolar disorder among patients with major depressive disorder in a commercially insured population.J Manag Care Pharm. 2008 Sep;14(7):631-42. J Manag Care Pharm. 2008. PMID: 18774873
Cited by
-
Dynamics of data-driven microstates in bipolar disorder.J Psychiatr Res. 2021 Sep;141:370-377. doi: 10.1016/j.jpsychires.2021.07.021. Epub 2021 Jul 16. J Psychiatr Res. 2021. PMID: 34304043 Free PMC article.
-
Urinary metabolite signature in bipolar disorder patients during depressive episode.Aging (Albany NY). 2019 Feb 5;11(3):1008-1018. doi: 10.18632/aging.101805. Aging (Albany NY). 2019. PMID: 30721880 Free PMC article.
-
Role of calcium channels in bipolar disorder.Curr Psychopharmacol. 2017;6(2):122-135. doi: 10.2174/2211556006666171024141949. Curr Psychopharmacol. 2017. PMID: 29354402 Free PMC article.
-
Association of CACNA1C Variants with Bipolar Disorder in the Korean Population.Psychiatry Investig. 2016 Jul;13(4):453-7. doi: 10.4306/pi.2016.13.4.453. Epub 2016 Jul 25. Psychiatry Investig. 2016. PMID: 27482248 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical